General Proximity

The next generation of induced-proximity medicines.

San Francisco, United States · Founded 2019 · $16.0M raised

Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$16.0M
Last Round
$8.0M Venture RoundMay 2026
Rounds
3

About

General Proximity is a San Francisco biotechnology platform company pioneering next-generation induced proximity medicines for undruggable targets. Its proprietary OmniTAC platform enables precise modification of disease-driving proteins across oncology, cardiometabolic disease, neurodegeneration, and longevity. Backed by Felicis, Y Combinator, age1, and ARPA-H grants.

Summary

General Proximity is a Biotech company based in San Francisco, United States, founded in 2019. It has raised $16.0M in total across 3 rounds, most recently a $8.0M Venture Round round in May 2026. Investors include Felicis Ventures, age1 and Rock Creek Capital.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Venture RoundVenture RoundMay 2026

Sign up to see all 3 rounds

Pre-Seed through Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

General Proximity on Indexed.vc
<a href="https://indexed.vc/companies/generalproximity"><img src="https://indexed.vc/api/badge/company/generalproximity" alt="General Proximity on Indexed.vc" width="260" height="76" /></a>